Ruh Roh
http://www.medscape....58684PR&spon=17
Posted 14 May 2013 - 11:42 PM
Posted 14 May 2013 - 11:58 PM
Posted 15 May 2013 - 12:56 AM
Posted 15 May 2013 - 01:53 AM
Posted 15 May 2013 - 11:43 AM
Posted 15 May 2013 - 12:13 PM
Posted 15 May 2013 - 07:29 PM
Posted 15 May 2013 - 07:37 PM
Why in the name of science would they use Olive Oil as a placebo? Were those conducting the study completely ignorant of the studies involving olive oil itself?
I am not even sure what to say about this.....
Posted 15 May 2013 - 09:26 PM
Why in the name of science would they use Olive Oil as a placebo? Were those conducting the study completely ignorant of the studies involving olive oil itself?
I am not even sure what to say about this.....
Posted 15 May 2013 - 09:49 PM
Posted 15 May 2013 - 10:56 PM
BTW, the study was looking at dosing with 1g of omega-3 fatty acids, not 1g of fish oil. Based on the EPA/DHA content of fish oil works out to about a tablespoon of fish oil, maybe a bit less. Please correct me if I'm wrong.
Edited by nameless, 15 May 2013 - 10:57 PM.
Posted 16 May 2013 - 12:01 AM
Posted 16 May 2013 - 12:08 AM
One gram of olive oil isn't going to do much of anything. In the Spanish cohort from the EPIC trial, where they looked at the health effects of olive oil consumption, the top quartile where the biggest health benefit was noted had an olive oil consumption of 30g/day. I don't think the argument that the placebo was "active" holds much water.
Posted 16 May 2013 - 12:25 AM
Why in the name of science would they use Olive Oil as a placebo? Were those conducting the study completely ignorant of the studies involving olive oil itself?
I am not even sure what to say about this.....
Exactly. Why is it they couldn't use plain water instead? I can see that then critics could point out that test subjects were getting an extra tablespoon or so of oil in their diets, but that would be a far better proxy for testing fish oil supplementation vs. non-supplementation.
BTW, the study was looking at dosing with 1g of omega-3 fatty acids, not 1g of fish oil. Based on the EPA/DHA content of fish oil works out to about a tablespoon of fish oil, maybe a bit less. Please correct me if I'm wrong.
Edited by Hebbeh, 16 May 2013 - 12:26 AM.
Posted 16 May 2013 - 12:39 AM
Edited by joelcairo, 16 May 2013 - 12:40 AM.
Posted 16 May 2013 - 03:09 AM
Arch Intern Med. 2012 May 14;172(9):686-94. doi: 10.1001/archinternmed.2012.262.
Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials.
Kwak SM, Myung SK, Lee YJ, Seo HG; Korean Meta-analysis Study Group.
Center for Cancer Prevention and Detection, Ilsan, Republic of Korea.
BACKGROUND:
Although previous randomized, double-blind, placebo-controlled trials reported the efficacy of omega-3 fatty acid supplements in the secondary prevention of cardiovascular disease (CVD), the evidence remains inconclusive. Using a meta-analysis, we investigated the efficacy of eicosapentaenoic acid and docosahexaenoic acid in the secondary prevention of CVD.
METHODS:
We searched PubMed, EMBASE, and the Cochrane Library in April 2011. Two of us independently reviewed and selected eligible randomized controlled trials.
RESULTS:
Of 1007 articles retrieved, 14 randomized, double-blind, placebo-controlled trials (involving 20 485 patients with a history of CVD) were included in the final analyses. Supplementation with omega-3 fatty acids did not reduce the risk of overall cardiovascular events (relative risk, 0.99; 95% CI, 0.89-1.09), all-cause mortality, sudden cardiac death, myocardial infarction, congestive heart failure, or transient ischemic attack and stroke. There was a small reduction in cardiovascular death (relative risk, 0.91; 95% CI, 0.84-0.99), which disappeared when we excluded a study with major methodological problems. Furthermore, no significant preventive effect was observed in subgroup analyses by the following: country location, inland or coastal geographic area, history of CVD, concomitant medication use, type of placebo material in the trial, methodological quality of the trial, duration of treatment, dosage of eicosapentaenoic acid or docosahexaenoic acid, or use of fish oil supplementation only as treatment.
CONCLUSION:
Our meta-analysis showed insufficient evidence of a secondary preventive effect of omega-3 fatty acid supplements against overall cardiovascular events among patients with a history of cardiovascular disease.
Comment in
ACP Journal Club: review: omega-3 fatty acid supplements provide no protective benefit in cardiovascular disease. [Ann Intern Med. 2012]
The big ones that got away: omega-3 meta-analysis flawed by excluding the biggest fish oil trials. [Arch Intern Med. 2012]
Omega-3 fatty acids and secondary prevention of cardiovascular disease-is it just a fish tale?: comment on “Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease”. [Arch Intern Med. 2012]
PMID: 22493407
Posted 16 May 2013 - 04:42 AM
Posted 16 May 2013 - 12:30 PM
Here's a published response to the preceding study. I don't have a strong opinion on this subject either way, BTW. I do take fish oil but not for cardio protection. What I do have strong feelings about is doctors like EricTopol prematurely trumpeting that we have "proof" that fish oil "does nothing". Certainty is the enemy of wisdom.
The Big Ones That Got Away: Omega-3 Meta-analysis Flawed by Excluding the Biggest Fish Oil Trials
http://archinte.jama...ticleid=1377495
Posted 16 May 2013 - 02:16 PM
Although simplified, and rather old, wasn't it stated that the Eskimo population who consume high amounts of fat and EFA's naturally in their diet had one of the lowest incidents on cardiovascular disease?
Posted 16 May 2013 - 05:27 PM
The guy who does the large mouse screenings, someone remind me what his name was (they have been discussed in more than one recent thread) said at a rcent conference that fish oil not only didn't extend lifespan, but actually had a negative effect.
Of course mice are not people, but just thought it worth mentioning.
Posted 27 May 2013 - 11:23 AM
I'm not sure I buy Topol's logic regarding the trial population. They were in pretty bad shape- hypercholesterolemic, diabetic, and atherosclerotic. He says if fish oil doesn't help them, it won't help anyone. Maybe if they'd used fish oil before they were such a mess, they'd be healthier. The trial showed that fish oil isn't a miracle cure for people on the verge of a cardiovascular event. To try to extend it to healthy people seems like a stretch.
Posted 11 July 2013 - 01:48 PM
Edited by nowayout, 11 July 2013 - 01:49 PM.
Posted 14 July 2013 - 11:22 AM
Posted 17 August 2013 - 05:01 AM
STUDY PROCEDURES
Study patients were randomly assigned to receive one capsule daily containing 1 g of n−3 fatty acids (polyunsaturated fatty acid ethyl esters with eicosapentaenoic acid and docosahexaenoic acid content not <85%, in a ratio that could range from 0.9:1 to 1.5:1) or placebo (olive oil). Treatment was centrally assigned by means of telephone on the basis of a concealed, computer-generated randomization list, stratified according to general practitioner. Patients, general practitioners, coordination and statistical staff, and outcome assessors were unaware of the study assignments until the final analyses were completed.
Posted 17 August 2013 - 10:09 PM
They got as little as 850mg of EPA+DHA. In both groups, about 24% never ate fish, 43% ate fish once a week, 27% twice, and 6% three or more times per week.
It's an interesting study. I would like to have seen a dose of 2-3 grams EPA+DHA.
0 members, 3 guests, 0 anonymous users